ACR 2013 – Association of T follicular helper / Th17 T cell and memory B cell populations in rheumatoid arthritis with disease activity and therapy with TNF antagonists

ACR 2013 – Can Modulators of Inflammation Serve as Biomarkers for Subclinical Atherosclerosis in Rheumatoid Arthritis?

ACR 2013 – Categorization of Rheumatoid Arthritis Subjects by Rheumatoid Factor and Anti-Cyclic Citrullinated Autoantibody Status Identifies Rheumatoid Arthritis Subjects with Different Clinical Characteristics

ACR 2013 – FACTORS ASSOCIATED WITH DECISIONS TO ADJUST THERAPY FOR RHEUMATOID ARTHRITIS PATIENTS IN MODERATE TO HIGH DISEASE ACTIVITY

ACR 2013 – Factors that affect tender and swollen joint counts in rheumatoid arthritis

ACR 2013 – Identification of Factors Associated with Agreement Between Rheumatoid Arthritis Electronic Health Record (EHR) Medication Lists and Prescribed Disease Modifying Treatment Plans

ACR 2013 – Impact of basing rheumatoid arthritis disease activity measurement and treatment recommendations on patient instead of physician joint assessments

ACR 2013 – Patient versus Physician Joint Counts in Rheumatoid Arthritis Utilizing a Unique Self-Joint Examination Tool

ACR 2013 – Patients with Rheumatoid Arthritis have Impaired Candida albicans Specific Th17 Responses but Preserved Oral Candida albicans Protective Immunity

ACR 2013 – Physician and patient characteristics associated with the decision to treat rheumatoid arthritis patients with biologic monotherapy in usual care settings

ACR 2013 – RNA transcripts from peripheral blood mononuclear cells as predictors of clinical responsiveness in rheumatoid arthritis subjects treated with abatacept